H. Sung, J. Ferlay, R.L. Siegel, et al., Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209–249 (2021)

Article  PubMed  Google Scholar 

K.D. Shield, J. Ferlay, A. Jemal, et al., The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J. Clin. 67(1), 51–64 (2017)

Article  PubMed  Google Scholar 

J.P. Pignon, A. le Maître, E. Maillard, J. Bourhis, MACH-NC Collaborative Group, Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother. Oncol. 92(1), 4–14 (2009)

Article  Google Scholar 

J. Bauml, T.Y. Seiwert, D.G. Pfister, et al., Pembrolizumab for platinum- and cetuximab-refractory head and neck cancer: results from a single-arm, phase II study. J. Clin. Oncol. 35(14), 1542–1549 (2017)

Article  CAS  PubMed  PubMed Central  Google Scholar 

J.D. Schoenfeld, G.J. Hanna, V.Y. Jo, et al., Neoadjuvant nivolumab or nivolumab plus ipilimumab in untreated oral cavity squamous cell carcinoma: a phase 2 open-label randomized clinical trial. JAMA Oncol. 6(10), 1563–1570 (2020)

Article  PubMed  Google Scholar 

A. Marabelle, D.T. Le, P.A. Ascierto, et al., Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study. J. Clin. Oncol. 38(1), 1–10 (2020)

Article  CAS  PubMed  Google Scholar 

M.A. Curran, W. Montalvo, H. Yagita, J.P. Allison, PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proc. Natl. Acad. Sci. U. S. A. 107(9), 4275–4280 (2010)

Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

R.L. Ferris, G. Blumenschein Jr, J. Fayette, et al., Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 375(19), 1856–1867 (2016)

Article  PubMed  PubMed Central  Google Scholar 

L.Q.M. Chow, Head and neck cancer. N. Engl. J. Med. 382(1), 60–72 (2020)

Article  CAS  PubMed  Google Scholar 

A. Chakravarthy, S. Henderson, S.M. Thirdborough, et al., Human papillomavirus drives tumor development throughout the head and neck: improved prognosis is associated with an immune response largely restricted to the oropharynx. J. Clin. Oncol. 34(34), 4132–4141 (2016)

Article  CAS  PubMed  PubMed Central  Google Scholar 

A.C. Chi, T.A. Day, B.W. Neville, Oral cavity and oropharyngeal squamous cell carcinoma–an update. CA Cancer J. Clin. 65(5), 401–421 (2015)

Article  PubMed  Google Scholar 

R.L. Ferris, et al., Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial. J. Immunother. Cancer 9(6), e002568 (2021)

Article  PubMed  PubMed Central  Google Scholar 

R. Cristescu, R. Mogg, M. Ayers, A. Albright, E. Murphy, J. Yearley, X. Sher, X.Q. Liu, H. Lu, M. Nebozhyn, et al., Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science 362, eaar3593 (2018)

Article  PubMed  PubMed Central  Google Scholar 

E.E.W. Cohen, R.B. Bell, C.B. Bifulco, et al., The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC). J. Immunother. Cancer 7(1), 184 (2019). Published 2019 Jul 15

Article  PubMed  PubMed Central  Google Scholar 

M.M. Galvis, G.A. Borges, T.B. Oliveira, et al., Immunotherapy improves efficacy and safety of patients with HPV positive and negative head and neck cancer: a systematic review and meta-analysis. Crit. Rev. Oncol. Hematol. 150, 102966 (2020)

Article  PubMed  Google Scholar 

Y.P. Chen, Y.Q. Wang, J.W. Lv, et al., Identification and validation of novel microenvironment-based immune molecular immunophenotypes of head and neck squamous cell carcinoma: implications for immunotherapy. Ann. Oncol. 30(1), 68–75 (2019)

Article  PubMed  Google Scholar 

J.A. Belk, B. Daniel, A.T. Satpathy, Epigenetic regulation of T cell exhaustion. Nat. Immunol. 23(6), 848–860 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

E. Gangoso, B. Southgate, L. Bradley, et al., Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion. Cell 184(9), 2454–2470.e26 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

G.P. Wagner, K. Kin, V.J. Lynch, Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples. Theory Biosci. 131(4), 281–285 (2012)

Article  CAS  PubMed  Google Scholar 

V. Thorsson, D.L. Gibbs, S.D. Brown, et al., The immune landscape of cancer. Immunity 48(4), 812–830.e14 (2018). [published correction appears in Immunity. 2019 Aug 20;51(2):411-412]

Article  CAS  PubMed  PubMed Central  Google Scholar 

D.A. Barbie, et al, Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462(5), 108–112 (2009)

Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

S. Hanzelmann, R. Castelo, J. Guinney, GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013)

Article  Google Scholar 

S. Monti, P. Tamayo, J. Mesirov, et al., Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Mach. Learn. 52, 91–118 (2003)

Article  Google Scholar 

Y. Șenbabaoğlu, G. Michailidis, J.Z. Li, Critical limitations of consensus clustering in class discovery. Sci. Rep. 4, 6207 (2014). Published 2014 Aug

Article  PubMed  PubMed Central  Google Scholar 

L. McInnes, J. Healy, N. Saul, L. Großberger, UMAP: uniform manifold approximation and projection. J. Open Source Softw. 3, 861 (2018)

A.M. Newman, C.L. Liu, M.R. Green, et al., Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12(5), 453–457 (2015)

Article  CAS  PubMed  PubMed Central  Google Scholar 

K. Yoshihara, M. Shahmoradgoli, E. Martinez, et al., Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013)

Article  PubMed  ADS  Google Scholar 

M. Lauss, M. Donia, K. Harbst, et al. Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma. Nat. Commun. 8:1738 (2017)

M.S. Rooney, S.A. Shukla, C.J. Wu, et al., Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160, 48–61 (2015)

Article  CAS  PubMed  PubMed Central  Google Scholar 

D. Aran, Z. Hu, A.J. Butte, xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18, 220 (2017)

Article  PubMed  PubMed Central  Google Scholar 

D.R. Spigel, A.B. Schrock, D. Fabrizio, et al., Total mutation burden(TMB) in lung cancer (LC) and relationship with response to PD-1/PD-L1 targeted therapies. J. Clin. Oncol. 34, 9017–7 (2016)

Article  Google Scholar 

N. Auslander, Y.I. Wolf, E.V. Koonin, Interplay between DNA damage repair and apoptosis shapes cancer evolution through aneuploidy and microsatellite instability. Nat. Commun. 11(1), 1234 (2020). Published 2020 Mar 6

Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

Y. Tian, T.J. Morris, A.P. Webster, et al., ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics 33(24), 3982–3984 (2017)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M.E. Ritchie, B. Phipson, D. Wu, et al., limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43(7), e47 (2015)

Article  PubMed  PubMed Central  Google Scholar 

Z. Xiong, F. Yang, M. Li, et al., EWAS Open Platform: integrated data, knowledge and toolkit for epigenome-wide association study. Nucleic Acids Res. 50(D1), D1004–D1009 (2022)

Article  CAS  PubMed  Google Scholar 

R. Tibshirani, Regression shrinkage and selection via the lasso. J. Roy. Stat. Soc. Ser. B (Methodological) 58, 267–288 (1996)

MathSciNet  Google Scholar 

A.M. Newman, C.L. Liu, M.R. Green, et al., Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453–457 (2015)

Article  CAS  PubMed  PubMed Central  Google Scholar 

A.E. Teschendorff, C.E. Breeze, S.C. Zheng, et al., A comparison of reference-based algorithms for correcting cell-type heterogeneity in epigenome-wide association studies. BMC Bioinform. 18, 105 (2017)

Article  Google Scholar 

S.C. Zheng, C.E. Breeze, S. Beck, A.E. Teschendorff, Identification of differentially methylated cell types in epigenome-wide association studies. Nat. Methods 15(12), 1059–1066 (2018)